Literature DB >> 28667360

Cortical venous disease severity in MELAS syndrome correlates with brain lesion development.

M T Whitehead1,2, M Wien3,4, B Lee5, N Bass3,4, A Gropman6.   

Abstract

PURPOSE: MELAS syndrome is a mitochondrial disorder typified by recurrent stroke-like episodes, seizures, and progressive brain injury. Abnormal mitochondria have been found in arterial walls implicating a vasculogenic etiology. We have observed abnormal cortical vein T2/FLAIR signal in MELAS patients, potentially representing wall thickening and sluggish flow. We sought to examine the relationship of hyperintense veins and brain lesions in MELAS.
METHODS: Imaging databases at two children's hospitals were searched for brain MRIs from MELAS patients. Artifact, sedated exams, and lack of 2D-T2/FLAIR sequences were exclusion criteria. Each exam was assigned a venous score based on number of T2/FLAIR hyperintense veins: 1 = <10, 2 = 10 to 20, 3 = >20. Cumulative brain lesions and venous score in MELAS and aged-matched normal exams were compared by Mann-Whitney test.
RESULTS: A total of 106 exams from 14 unique MELAS patients (mean 16 ± 3 years) and 30 exams from normal aged-matched patients (mean 15 ± 3 years) were evaluated. Median venous score between MELAS and control patients significantly differed (3 versus 1; p < 0.001). In the MELAS group, venous score correlated with presence (median = 3) or absence (median = 1) of cumulative brain lesions. In all 8 MELAS patients who developed lesions, venous hyperintensity was present prior to, during, and after lesion onset. Venous score did not correlate with brain lesion acuity.
CONCLUSION: Abnormal venous signal correlates with cumulative brain lesion severity in MELAS syndrome. Cortical venous stenosis, congestion, and venous ischemia may be mechanisms of brain injury. Identification of cortical venous pathology may aid in diagnosis and could be predictive of lesion development.

Entities:  

Keywords:  FLAIR; MELAS; Mitochondria; Vasculature; Veins; Vessels

Mesh:

Year:  2017        PMID: 28667360     DOI: 10.1007/s00234-017-1866-3

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  20 in total

1.  Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome.

Authors:  P M Matthews; D Tampieri; S F Berkovic; F Andermann; K Silver; D Chityat; D L Arnold
Journal:  Neurology       Date:  1991-07       Impact factor: 9.910

2.  A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.

Authors:  Y Goto; I Nonaka; S Horai
Journal:  Nature       Date:  1990-12-13       Impact factor: 49.962

Review 3.  When should MELAS (Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes) be the diagnosis?

Authors:  Paulo José Lorenzoni; Lineu Cesar Werneck; Cláudia Suemi Kamoi Kay; Carlos Eduardo Soares Silvado; Rosana Herminia Scola
Journal:  Arq Neuropsiquiatr       Date:  2015-11       Impact factor: 1.420

Review 4.  Imaging of MELAS.

Authors:  Konark Malhotra; David S Liebeskind
Journal:  Curr Pain Headache Rep       Date:  2016-09

5.  Differential diagnosis of mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) and ischemic stroke using 3D pseudocontinuous arterial spin labeling.

Authors:  Rui Li; Hua-Feng Xiao; Jin-Hao Lyu; Danny J J Wang; Lin Ma; Xin Lou
Journal:  J Magn Reson Imaging       Date:  2016-06-27       Impact factor: 4.813

6.  MELAS: a nationwide prospective cohort study of 96 patients in Japan.

Authors:  Shuichi Yatsuga; Nataliya Povalko; Junko Nishioka; Koju Katayama; Noriko Kakimoto; Toyojiro Matsuishi; Tatsuyuki Kakuma; Yasutoshi Koga
Journal:  Biochim Biophys Acta       Date:  2011-04-02

Review 7.  The use of neuroimaging in the diagnosis of mitochondrial disease.

Authors:  Seth D Friedman; Dennis W W Shaw; Gisele Ishak; Andrea L Gropman; Russell P Saneto
Journal:  Dev Disabil Res Rev       Date:  2010

8.  Diffusion and perfusion characteristics of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode) in thirteen patients.

Authors:  Ji Hye Kim; Myung Kwan Lim; Tae Yeon Jeon; Joung Ho Rha; Jung Ho Rha; Hong Eo; So-Young Yoo; Chang Hae Shu
Journal:  Korean J Radiol       Date:  2011-01-03       Impact factor: 3.500

9.  Mitochondrial disorders: analysis of their clinical and imaging characteristics.

Authors:  A J Barkovich; W V Good; T K Koch; B O Berg
Journal:  AJNR Am J Neuroradiol       Date:  1993 Sep-Oct       Impact factor: 3.825

10.  Phenotypic analysis of epilepsy in the mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes-associated mitochondrial DNA A3243G mutation.

Authors:  Scott T Demarest; Matthew T Whitehead; Sinan Turnacioglu; Phillip L Pearl; Andrea L Gropman
Journal:  J Child Neurol       Date:  2014-07-17       Impact factor: 1.987

View more
  5 in total

1.  Restrictive cerebral cortical venopathy: A new clinicopathological entity.

Authors:  Zoya A Voronovich; Kathy Wolfe; Kimberly Foster; Danielle Sorte; Andrew P Carlson
Journal:  Interv Neuroradiol       Date:  2019-02-04       Impact factor: 1.610

2.  Response regarding involvement of the cerebral veins in MELAS syndrome.

Authors:  Matthew T Whitehead; Michael Wien; Bonmyong Lee; Nancy Bass; Andrea Gropman
Journal:  Neuroradiology       Date:  2017-08-11       Impact factor: 2.804

Review 3.  Cerebral imaging in paediatric mitochondrial disorders.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Neuroradiol J       Date:  2018-07-06

4.  Involvement of the cerebral veins in MELAS syndrome?

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Neuroradiology       Date:  2017-07-18       Impact factor: 2.804

Review 5.  Magnetic resonance imaging of arterial stroke mimics: a pictorial review.

Authors:  Gilles Adam; Marine Ferrier; Sofia Patsoura; Raluca Gramada; Zuzana Meluchova; Vanessa Cazzola; Jean Darcourt; Christophe Cognard; Alain Viguier; Fabrice Bonneville
Journal:  Insights Imaging       Date:  2018-06-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.